New therapy for aggressive blood cancer discovered

Acute myeloid leukemia (AML) is the most common form of acute leukemia. It is characterized by an increase of malignant myeloid progenitor cells at the expense of mature blood cells. Only twenty-five percent of all AML patients survive five years beyond the initial diagnosis. Therefore there is an urgent need to deepen the knowledge about this form of blood cancer and to develop new therapeutic approaches.

Source: sciencedaily.com

Related posts

Non-stop flight: 4,200 km transatlantic flight of the Painted Lady butterfly mapped

Your future medications could be personalized for you on a 3D printer

Next platform for brain-inspired computing